Dr. Parag Ramesh Sevak, MD

Dr. Sevak practices at Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky.

Dr. Sevak's NPI, 1558705210, was assigned on April 24, 2013. Dr. Sevak graduated from University of Texas Medical Branch at Galveston in 2013. Dr. Sevak holds Indiana license 01080855A.

Dr. Sevak's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD, at 4960 Norton Healthcare Blvd, Louisville, KY 40241.

Dr. Sevak's primary practice is Norton Brownsboro Hospital-Operating Room - HOPD in Louisville, Kentucky. Dr. Sevak is also affiliated with Norton Hospital. The medical group on file is Norton Cancer Institute. Dmand AI also links Dr. Sevak to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Sevak practices, 7 sites in all. Vendor and product names are available with a free account.

Radiation oncology is Dr. Sevak's primary specialty in the NPI Registry, under taxonomy code 2085R0001X. Dmand AI has Dr. Sevak's licenses on file in 2 states: Indiana and Kentucky.

CMS data shows 1,959 Medicare services from Dr. Sevak across 20 procedure codes in 2024, for 269 Medicare patients. Medicare paid $127,515 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 269 Medicare patients who saw Dr. Sevak in 2024. The largest group is 65 to 74, with 125 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 9% are also on Medicaid. Their average risk score is 1.87, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Sevak's median patient age at 72, with 52% women.

In 2024, Dr. Sevak wrote 139 Medicare Part D claims for 74 patients. 94% of them were for generic drugs. CMS names the drug for 78 of them, across 3 drugs with 11 or more claims each, at $1,098 in total drug cost. In 2023, CMS named 41 claims across 3 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 84 out of 100 for Dr. Sevak for performance year 2024, reported as part of a group. Dr. Sevak accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Sevak as offering telehealth.

Dmand AI links 10 papers to Dr. Sevak, published from 2013 to 2025. 2014 was the busiest year, with 2. The most frequent topics are Radiotherapy Planning, Computer-Assisted, Chemotherapy, Adjuvant and Organs at Risk. Dr. Sevak has published most often in J Appl Clin Med Phys. Dr. Sevak's most frequent co-authors are Mohamed A. Elshaikh, MD, Kaylyn Deanne Sinicrope, MD and David A. Sun, MD.

CMS Open Payments shows 30 general payments to Dr. Sevak from 20 drug and device companies from 2018 to 2024. Food and beverage make up the largest share, 100% of the total. Bristol-Myers Squibb Company paid the most, $60.

Dr. Sevak graduated from University of Texas Medical Branch at Galveston in 2013.